(Q36600512)

15 August 2017

1 reference

title

The role of endometrium in endometriosis (English)

1 reference

15 August 2017

1 reference

3

Aydin Arici

1 reference

15 August 2017

Murat Ulukus

1

1 reference

PubMed ID

16990031

15 August 2017

Hakan Cakmak

series ordinal

2

1 reference

15 August 2017

20 September 2006

1 reference

15 August 2017

Reproductive Sciences

1 reference

15 August 2017

13

1 reference

15 August 2017

7

1 reference

15 August 2017

467-476

1 reference

Whole explants of peritoneum and endometrium: a novel model of the early endometriosis lesion

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Culture of menstrual endometrium with peritoneal explants and mesothelial monolayers confirms attachment to intact mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Cell adhesion molecules and endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Expression of the alpha2beta1 and alpha3beta1 integrins at the surface of mesothelial cells: a potential attachment site of endometrial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Regulation of matrix metalloproteinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Paracrine mediators of endometrial matrix metalloproteinase expression: potential targets for progestin-based treatment of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Adhesion of menstrual endometrium to extracellular matrix: the possible role of integrin alpha(6)beta(1) and laminin interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Matrix metalloproteinases and endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Reduced progesterone action during endometrial maturation: a potential risk factor for the development of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Apoptosis and the pathogenesis of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Reduction of apoptosis and proliferation in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Apoptosis in human endometrium and endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Immunology and Endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Regulation of Fas ligand expression by vascular endothelial growth factor in endometrial stromal cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Endometrial anomalies in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Heat shock proteins in human endometrium throughout the menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Expression of heat shock protein 70 kDa in human endometrium of normal and infertile women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Interleukin 6 induces the expression of vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Interleukin-8 as a macrophage-derived mediator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Uterine chemokines in reproductive physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Pathogenetic significance of increased levels of interleukin-8 in the peritoneal fluid of patients with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Immunobiology of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Vascular endothelial growth factor (VEGF) in endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Structural organization and the transcription initiation site of the human hepatocyte growth factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Endometriosis: the ultimate hormonal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Aromatase inhibitors: the next generation of therapeutics for endometriosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Anastrazole and oral contraceptives: a novel treatment for endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Endometriotic lesions synthesize and secrete a haptoglobin-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

The role of HOX genes in human implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

HOX gene expression is altered in the endometrium of women with endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

EMX2 gene expression in the female reproductive tract and aberrant expression in the endometrium of patients with endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Maternal IL-11Ralpha function is required for normal decidua and fetoplacental development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Interleukin-11 (IL-11) in human endometrium: expression throughout the menstrual cycle and the effects of cytokines on endometrial IL-11 production in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Pathogenesis of endometriosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

Production of Prostaglandin F2α by Cultured Bovine Endometrial Cells in Response to Tumor Necrosis Factor α: Cell Type Specificity and Intracellular Mechanisms1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.JSGI.2006.07.005

10.1016/J.JSGI.2006.07.005

21 January 2018

Identifiers

DOI

0 references

PubMed ID

16990031

1 reference

PubMed ID

16990031